{"id":6114,"date":"2025-03-28T08:49:21","date_gmt":"2025-03-28T07:49:21","guid":{"rendered":"https:\/\/www.ehc.eu\/non-classifiee\/declaration-de-novo-nordisk-sur-les-questions-de-fabrication-liees-a-novoseven-novoeight-et-esperoct\/"},"modified":"2026-04-02T16:31:33","modified_gmt":"2026-04-02T14:31:33","slug":"declaration-de-novo-nordisk-sur-les-questions-de-fabrication-liees-a-novoseven-novoeight-et-esperoct","status":"publish","type":"post","link":"https:\/\/www.ehc.eu\/fr\/nouvelles\/declaration-de-novo-nordisk-sur-les-questions-de-fabrication-liees-a-novoseven-novoeight-et-esperoct\/","title":{"rendered":"D\u00e9claration de Novo Nordisk sur les questions de fabrication li\u00e9es \u00e0 NovoSeven, NovoEight et Esperoct"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n<!-- hero -->\t<section   class=\"subpage-hero bg-white\">\n\t\t<div class=\"container\">\n\t\t\t<div class=\"relative z-10\">\n\t\t\t\t<div class=\"pt-16 lg:pt-24 pb-24 lg:pb-32\">\n\t\t\t\t\t<div class=\"row justify-between gap-10 lg:gap-0 mt-10 text-center lg:text-left\">\n\t\t\t\t\t\t<div class=\"w-full lg:w-6\/12 lg:self-center\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"title h2\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t\t<p class=\"text-[115%]\">D\u00e9claration de Novo Nordisk sur les questions de fabrication li\u00e9es \u00e0 NovoSeven, NovoEight et Esperoct<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<figure class=\"absolute size-[41.8rem] lg:size-[82.8rem] bottom-[-10%] right-[-10rem] lg:right-[-5%] image-contain opacity-100 skip-lazy\" data-parallax>\n\t\t\t\t\t<img decoding=\"async\" loading=\"eager\" src=\"https:\/\/www.ehc.eu\/wp-content\/themes\/cbd\/img\/content-logo-colorfull-2.svg\" alt=\"content-logo-colorfull\">\n\t\t\t\t<\/figure>\n\t\t\t\t\t\t<\/section>\n<!-- overview -->\t<section   class=\"s-overlay-img s-padding bg-red\">\n\t\t<div class=\"container\">\n\t\t\t<div class=\"row w-full lg:flex-row justify-between text-center lg:text-left gap-14 lg:gap-0 relative z-10\">\n\t\t\t\t\t\t\t\t<div class=\"w-full lg:py-10\">\n\t\t\t\t\t<div class=\"bg-white min-h-full py-12 px-10 lg:py-24 lg:pl-24 xl:pl-44 relative radius-20 z-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"content mt-8\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t<p><!-- wp:paragraph --><\/p>\n<p>Il y a quelques jours, l\u2019EHC a re\u00e7u une d\u00e9claration de Novo Nordisk concernant des probl\u00e8mes de fabrication li\u00e9s \u00e0 NovoSeven, NovoEight et Esperoct.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph {\"fontSize\":\"medium\"} --><\/p>\n<p class=\"has-medium-font-size\"><em>\u00ab\u00a0<strong>Le probl\u00e8me pr\u00e9c\u00e9dent des fioles potentiellement sous-remplies dans certains lots de NovoSeven\u00ae 1 mg et 2 mg, NovoEight\u00ae et Esperoct\u00ae a \u00e9t\u00e9 r\u00e9solu. Par cons\u00e9quent, la situation de l\u2019offre de NovoSeven\u00ae devrait se stabiliser progressivement tout au long de 2025, suivie d\u2019une reconstruction des stocks. De plus, Novo Nordisk collabore avec les autorit\u00e9s sanitaires locales et l\u2019EMA pour mettre en \u0153uvre des mesures temporaires d\u2019att\u00e9nuation visant \u00e0 garantir la flexibilit\u00e9 de l\u2019approvisionnement dans toute l\u2019UE et \u00e0 minimiser les perturbations au niveau des patients. Dans l\u2019ensemble, des efforts continus sont d\u00e9ploy\u00e9s pour garantir une production stable et un approvisionnement fiable pour les patients. \u00bb   <\/strong><\/em><\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>Novo Nordisk a ajout\u00e9 qu\u2019il est important de noter que la situation en temps r\u00e9el peut varier d\u2019un pays \u00e0 l\u2019autre et recommande aux organisations locales de patients de travailler en \u00e9troite collaboration avec l\u2019affili\u00e9 local de Novo Nordisk directement pour traiter toute pr\u00e9occupation li\u00e9e \u00e0 l\u2019approvisionnement.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>L\u2019EHC continuera de surveiller la situation et serait reconnaissant d\u2019\u00eatre inform\u00e9 par ses membres si l\u2019un d\u2019entre vous rencontre des probl\u00e8mes sp\u00e9cifiques ou a des pr\u00e9occupations.<\/p>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Il y a quelques jours, l\u2019EHC a re\u00e7u une d\u00e9claration de Novo Nordisk concernant des probl\u00e8mes de fabrication li\u00e9s \u00e0 NovoSeven, NovoEight et Esperoct.<\/p>\n","protected":false},"author":2,"featured_media":4096,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[64],"tags":[],"class_list":["post-6114","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles"],"acf":[],"jetpack_featured_media_url":"https:\/\/www.ehc.eu\/wp-content\/uploads\/2025\/03\/treatment-update-Blog-Banner.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/posts\/6114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/comments?post=6114"}],"version-history":[{"count":1,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/posts\/6114\/revisions"}],"predecessor-version":[{"id":6117,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/posts\/6114\/revisions\/6117"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/media\/4096"}],"wp:attachment":[{"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/media?parent=6114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/categories?post=6114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ehc.eu\/fr\/wp-json\/wp\/v2\/tags?post=6114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}